News Briefing channel feed

Au­to­lus claims a CAR-T win at EHA; Ima­go touts two PhII tri­al wins for rare dis­ease drug

4 years ago

Verona signs Chi­na deal for PhI­II COPD drug; Te­va con­tin­ues le­gal bat­tle with Eli Lil­ly, al­leg­ing new patent in­fringe­ments on mi­graine drug

4 years ago

Em­ploy­ees in Flori­da IBS tri­al plead guilty for fal­si­fy­ing med­ical records; Cys­tic fi­bro­sis tablet Trikaf­ta now avail­able for chil­dren 6 and old­er

4 years ago

In­cyte faces de­lay on FDA's Jakafi de­ci­sion for cGVHD; Bay­er's Parkin­son's cell ther­a­py en­ters the clin­ic

4 years ago

Spring­Works and Seagen team up in mul­ti­ple myelo­ma; Mer­ck and Ei­sai build out Keytru­da/Lenvi­ma da­ta

4 years ago

Fate sees pos­i­tive B-cell lym­phoma da­ta at #AS­CO21; Imag­inAb se­cures fund­ing for CD8 imag­ing tri­als

5 years ago

Mer­ck­'s wom­en's health spin­off goes pub­lic in NYSE de­but; A Hous­ton an­ti­body play­er scores fresh funds to chase tu­mors

5 years ago

Cell­tri­on's rheuma­toid arthri­tis drug meets both end­points in PhI­II; New com­pa­ny Tri­bune emerges to take on fi­brot­ic dis­eases

5 years ago

Broad In­sti­tute's Er­ic Lan­der con­firmed to Biden cab­i­net; Leg­end re­veals the BC­MA CAR-T da­ta pack­age be­hind pri­or­i­ty re­view

5 years ago

Chi­na's patent law re­vi­sions set to take ef­fect June 1; Ver­ri­ca's sec­ond trip to the FDA is de­layed

5 years ago

Astel­las out­lines an­oth­er five-year plan; Bay­er's VC arm leaps in­to dig­i­tal health

5 years ago

PureTech's video game for AD­HD gets big Se­ries D fi­nanc­ing; Day One in­creas­es term sheet ahead of ex­pect­ed IPO

5 years ago

New da­ta point to how Keytru­da changed lung can­cer treat­ment; A Hous­ton biotech earns ear­ly back­ers in quest to turn 'cold' tu­mors 'hot'

5 years ago

Ve­rastem wins break­through nod for com­bo ther­a­py in ovar­i­an can­cer; EMA picks up speedy re­view of Bio­Mar­in's gene ther­a­py

5 years ago

An­no­vis Bio claims wins in Alzheimer's and Parkin­son's, shares sky­rock­et; FDA de­lays de­ci­sion for Omeros' nar­so­plimab

5 years ago

Bio­Th­eryX col­lects $92M in Se­ries E round; WuXi Bi­o­log­ics ups its stake in an emerg­ing ADC play­er

5 years ago

Idera of­fi­cial­ly puts to rest its Phase III tri­al in ad­vanced melanoma; BeiGene nabs pri­or­i­ty re­view for sN­DA

5 years ago

Lil­ly and In­novent look to bring their an­ti-PD-1 from Chi­na to the US; Mer­ck KGaA names new EMD Serono pres­i­dent

5 years ago

John­son & John­son do­nates Ebo­la vac­cine amid new out­break; Ji Xing promis­es more than $127M for Mile­stone's nasal spray for rapid heart rate

5 years ago

Scynex­is takes out $60M loan ahead of ex­pect­ed ap­proval; Com­pass Ther­a­peu­tics ac­quires new bis­pe­cif­ic an­ti­body in buy­out

5 years ago

AI life sci­ences uni­corn rais­es $150M for plat­form ops; 10 rare dis­ease com­pa­nies form new lob­by­ing group

5 years ago

Sanofi, Cel­lec­tis team up to pair Lem­tra­da with al­lo­gene­ic CAR-Ts; Bris­tol My­ers joins Evotec's dri­ve to ad­vance UK sci­ence

5 years ago

Prothena col­lects $60M Parkin­son's mile­stone from Roche; As­traZeneca's Pas­cal So­ri­ot faces proxy push­back on pay pack­age

5 years ago

British CRO wins con­tract for Covid-19 chal­lenge virus; Dutch agency aims to slash Zol­gens­ma prices in half

5 years ago
First page Previous page 30313233343536 Next page Last page
A service from the Financial Times